Do You Know Your suPARnostic® Level?
ViroGates has developed a unique prognostic biomarker - suPARnostic®, measuring the soluble blood protein suPAR, present in everybody. Independent of the respective condition, an elevated suPAR level is a master alarm for a patient's risk status. In clinical practice suPARnostic® can be used for patient triaging in critical care as well as monitoring of treatment efficacy and success. suPARnostic®'s amazing prognostic value has already been exemplified in various infectious conditions, these include sepsis/SIRS, tuberculosis and HIV.
ViroGates first commercial suPARnostic® product is an ELISA-based test that has been launched in certain European, African and Asian countries. A suPARnostic® Flex ELISA kit for clinical testing is now also available, as well as the new suPARnostic® Quick Triage - a Point of Care Test Device for early Warning and Intervention . For more information on the suPARnostic® products please visit our Product Page on www.suparnostic.com